Co-Infection of COVID-19 and Pneumocystosis Following Rituximab Infusion—A Case Report
Transplantology
; 3(1):83, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1818208
ABSTRACT
Immunocompromised patients with respiratory viral infections are at increased risk of fungal superinfections, including Pneumocystosis. Within the scope of the COVID-19 pandemic, Pneumocystis jirovecii co-infections are being increasingly reported. Differential diagnosis often creates a dilemma, due to multiple overlapping clinical and radiographic features. Awareness of fungal co-infections in the context of the COVID-19 pandemic is crucial to initiate prophylactic measures, especially in high-risk individuals. We report the second case of Pneumocystis jirovecii pneumonia and COVID-19 co-infection in a renal transplant recipient in Poland.
Medical Sciences--Surgery; COVID-19; kidney transplantation; Pneumocystis; Laboratories; Ventilators; Transplants & implants; Acidosis; Severe acute respiratory syndrome coronavirus 2; Influenza; Renal replacement therapy; Patients; Human immunodeficiency virus--HIV; Pneumonia; Blood pressure; Immune system; Pandemics; Biopsy; Edema; Lymphocytes; Viruses; Streptococcus infections; Viral infections; Coronaviruses; Intensive care; Ultrasonic imaging; Creatinine; Disease transmission; Poland
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Case report
Language:
English
Journal:
Transplantology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS